GPR30 activation improves memory and facilitates DHPG-induced LTD in the hippocampal CA3 of middle-aged mice

Neurobiol Learn Mem. 2018 Mar:149:10-19. doi: 10.1016/j.nlm.2018.02.005. Epub 2018 Feb 6.

Abstract

Reduced estrogen levels and decreased expression of related receptors are typical cerebral features of aging. The G protein-coupled estrogen receptor 1 (GPER1, also known as GPR30) is considered a novel therapeutic target for neurodegenerative diseases. In this study, we demonstrated that hippocampal GPR30 expression was reduced in middle-aged mice compared with young adult mice. GPR30 agonist G1 improved both fear and spatial memory in both male and female middle-aged mice, but not in young adult mice, which were blocked by the GPR30 antagonist G15. Interestingly, a group I metabotropic glutamate receptor (mGluR) agonist, 3,5-dihydroxyphenylglycine (DHPG)-induced long-term depression (LTD) in mossy fiber-cornu ammonis 3 (MF-CA3) synapses but not Schaffer collateral-CA1 (SC-CA1) synapses was facilitated in brain slices from G1-treated middle-aged mice. Long-term potentiation (LTP) in SC-CA1 synapses was not affected in slices from G1-treated mice. The effects of GPR30 activation on memory and DHPG-LTD in MF-CA3 synapses were further confirmed by viral expression of GPR30 in the CA3. The regulation of hippocampal synaptic plasticity by G1 treatment might be related to brain-derived neurotrophic factor (BDNF)-tropomyosin receptor kinase B (TrkB) signaling, as G15 also blocked G1-induced activation of the BDNF-TrkB pathway. Moreover, we found that DHPG triggered GluA internalization in slices from G1-treated mice but not control mice. Pharmacological experiments showed that G1-mediated facilitation of DHPG-induced LTD in MF-CA3 synapses was dependent on protein kinase B (Akt), mammalian target of rapamycin (mTor), and TrkB signaling. In conclusion, our results indicate that GPR30 activation improves memory in middle-aged mice, likely through facilitating synaptic plasticity in the CA3. This study provides novel evidence that GPR30 activation can improve memory in middle-aged animals.

Keywords: Aging; BDNF; GPR30; Long-term depression; Memory deficit.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Animals
  • Benzodioxoles / pharmacology
  • Brain-Derived Neurotrophic Factor / metabolism
  • CA3 Region, Hippocampal / drug effects*
  • CA3 Region, Hippocampal / metabolism
  • Excitatory Amino Acid Agonists / pharmacology*
  • Fear / drug effects
  • Female
  • Long-Term Synaptic Depression / drug effects*
  • Male
  • Membrane Glycoproteins / metabolism
  • Methoxyhydroxyphenylglycol / analogs & derivatives*
  • Methoxyhydroxyphenylglycol / pharmacology
  • Mice
  • Neuronal Plasticity / drug effects
  • Protein-Tyrosine Kinases / metabolism
  • Quinolines / pharmacology
  • Receptors, Estrogen / antagonists & inhibitors*
  • Receptors, Estrogen / metabolism
  • Receptors, G-Protein-Coupled / antagonists & inhibitors*
  • Receptors, G-Protein-Coupled / metabolism
  • Receptors, Metabotropic Glutamate / agonists
  • Signal Transduction / drug effects
  • Spatial Memory / drug effects
  • Synapses / drug effects
  • Synapses / metabolism

Substances

  • 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline
  • Benzodioxoles
  • Brain-Derived Neurotrophic Factor
  • Excitatory Amino Acid Agonists
  • GPER1 protein, mouse
  • Membrane Glycoproteins
  • Quinolines
  • Receptors, Estrogen
  • Receptors, G-Protein-Coupled
  • Receptors, Metabotropic Glutamate
  • metabotropic glutamate receptor type 1
  • Methoxyhydroxyphenylglycol
  • Ntrk2 protein, mouse
  • Protein-Tyrosine Kinases
  • 3,4-dihydroxyphenylglycol